astrazeneca cspc - Search News

News

CSPC, AstraZeneca and AI

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions.

The Wall Street Journal on MSN · 3d

AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion

The deal with China’s CSPC Pharmaceuticals, focused on AI-driven research, aims to advance the discovery and development of new drug candidates.

BioSpace · 3d

AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

Fierce Biotech3d

AstraZeneca pens $5.3B pact to use CSPC's AI platform to develop oral drugs for chronic diseases

CSPC will use its artificial-intelligence-driven, dual-engine efficient drug discovery platform to analyze the binding ...

Pharmaceutical Technology on MSN2d

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

AstraZeneca is the latest pharma company enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with ...

Pharmabiz2d

AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research

AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research: Cambridge, UK Saturday, June 14, 2025, 09:00 Hrs [IST] AstraZeneca has entered a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results